Drug prevents bone loss in prostate cancer: Amgen
Monday, July 14, 2008 - 12:07
in Health & Medicine
CHICAGO (Reuters) - Amgen Inc on Monday said that a trial of its experimental drug denosumab showed that it can prevent osteoporosis in men being treated with prostate cancer drugs that can cause bone loss.